首页|Sanhua Tang(三化汤)protects against ischemic stroke by preventing blood-brain barrier injury:a network pharmacology and in vivo experiments

Sanhua Tang(三化汤)protects against ischemic stroke by preventing blood-brain barrier injury:a network pharmacology and in vivo experiments

扫码查看
Sanhua Tang(三化汤)protects against ischemic stroke by preventing blood-brain barrier injury:a network pharmacology and in vivo experiments
OBJECTIVE:To assess the effect and mechanism of Sanhua Tang(三化汤,SHT)in treating ischemic stroke(IS)through the"Kaitong Xuanfu"theory by using network pharmacology and animal experiments.METHODS:The active ingredients and targets of SHT and IS were screened by public databases such as Traditional Chinese Medicine systems pharmacology,GeneCards,and online mendelian inheritance in man.Visual network topographies were constructed using R,Cytoscape 3.6.0,AutoDockTools,a user-sponsored molecular visualization system on an open-source foundation,and other software to analyze the correlation between targets and active ingredients.The middle cerebral artery occlusion(MCAO)model was established by operation.Animals were divided into the Sham group,MCAO group(M group),aloe-emodin(AE)group(MCAO rats treated with aloe-emodin),SHT at low dosage(SL group)(MCAO rats treated with SL),SHT at medium dosage(SM group),and SHT at high dosage(SH group).2,3,5-triphenyl tetrazolium chloride staining was used to detect the volume of cerebral infarction;Nissl staining was used to observe the morphology of neuronal cells;transmission electron microscopy was used to observe the integrity of the blood-brain barrier(BBB);enzyme-linked immunosorbent assay was used to detect the content of interleukin-6(IL-6),IL-10,tumor necrosis factorα(TNF-α)in serum.Western blot was used to detect the expression of vascular endothelial growth factor A(VEGFA)protein in the cerebral ischemic penumbra.RESULTS:Using network pharmacology and molecular docking validation,four active ingredients(lignan,naringenin,aloe-rhodopsin,and β-sitosterol),seven target proteins(protein kinase b 1,IL-6,TNF,VEGFA,TP53,jun proto-oncogene,and cysteinyl aspartate specific proteinase 3),and inflammatory signaling pathways were identified.Animal experiments showed that the SH and AE groups had fewer neurological deficits,reduced brain infarct volumes,decreased serum inflammatory factor levels,increased expression of VEGFA protein,and less structural damage to neurons and BBB.CONCLUSION:The present study found that the therapeutic mechanism of SHT against IS may be related to the inhibition of BBB inflammatory damage,which is also the mechanism of"Kaitong Xuanfu."The high-dose group of SHT was relatively effective in regulating inflammatory factors,improving BBB permeability,and protecting neuronal cells from damage.

network pharmacologyischemic strokeblood-brain barrierinflammatory reactionsSanhua Tang

LUO Shan、YANG Fan、CHEN Yuanchun、ZHAO Ruoxi、LIU Haiye、GAO Fei、MA Wencan、GAO Weijuan、YU Wentao

展开 >

College of Basic Medicine,Hebei University of Chinese Medicine,Shijiazhuang 050200,China

Graduate School,Hebei University of Chinese Medicine,Shijiazhuang 050091,China

College of Acupuncture and Massage,Hebei University of Chinese Medicine,Shijiazhuang 050200,China

Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Diseases,Shijiazhuang 050091,China

Hebei International Joint Research Centre for Acupuncture and Moxibustion of Traditional Chinese Medicine,Shijiazhuang 050091,China

展开 >

network pharmacology ischemic stroke blood-brain barrier inflammatory reactions Sanhua Tang

2024

中医杂志(英文版)
中国中医药学会 中国中医研究院

中医杂志(英文版)

影响因子:0.855
ISSN:0255-2922
年,卷(期):2024.44(4)